Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne M Mitchell

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|August 25, 2011
Access to the complement factor B scissile bond is facilitated by association of factor B with C3b proteinDennis E Hourcade, Lynne M Mitchell
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 28, 2023
A Monoclonal Antibody That Provides a Model for C3 Nephritic FactorsDennis E Hourcade, Lynne M Mitchell
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2008
The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosisClaudia Kemper, Lynne M Mitchell, Lijuan Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assemblyDirk Spitzer, Lynne M Mitchell, John P Atkinson, et al.
Molecular Immunology|December 18, 2015
Anti-complement activity of the Ixodes scapularis salivary protein Salp20Dennis E Hourcade, Antonina M Akk, Lynne M Mitchell, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 28, 2015
Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesisPaula Bertram, Antonina M Akk, Hui-fang Zhou, et al.
The Journal of Biological Chemistry|October 17, 2003
A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertasesLisa A Kuttner-Kondo, Megan P Dybvig, Lynne M Mitchell, et al.
Molecular Immunology|October 19, 2004
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in miceJoshua M Thurman, Damian M Kraus, Guillermina Girardi, et al.
The Journal of Biological Chemistry|November 5, 2010
Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfacesChristine T N Pham, Lynne M Mitchell, Jennifer L Huang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 12, 2013
Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticlesChristine T N Pham, Dennis G Thomas, Julia Beiser, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|August 25, 2011
Access to the complement factor B scissile bond is facilitated by association of factor B with C3b proteinDennis E Hourcade, Lynne M Mitchell
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 28, 2023
A Monoclonal Antibody That Provides a Model for C3 Nephritic FactorsDennis E Hourcade, Lynne M Mitchell
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2008
The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosisClaudia Kemper, Lynne M Mitchell, Lijuan Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assemblyDirk Spitzer, Lynne M Mitchell, John P Atkinson, et al.
Molecular Immunology|December 18, 2015
Anti-complement activity of the Ixodes scapularis salivary protein Salp20Dennis E Hourcade, Antonina M Akk, Lynne M Mitchell, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 28, 2015
Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesisPaula Bertram, Antonina M Akk, Hui-fang Zhou, et al.
The Journal of Biological Chemistry|October 17, 2003
A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertasesLisa A Kuttner-Kondo, Megan P Dybvig, Lynne M Mitchell, et al.
Molecular Immunology|October 19, 2004
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in miceJoshua M Thurman, Damian M Kraus, Guillermina Girardi, et al.
The Journal of Biological Chemistry|November 5, 2010
Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfacesChristine T N Pham, Lynne M Mitchell, Jennifer L Huang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 12, 2013
Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticlesChristine T N Pham, Dennis G Thomas, Julia Beiser, et al.
Pageof 2